Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-11-13
Original SEC Filing: Click here

---

Webplus: BSPM/20091113/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Announces Record Third Quarter 2009 Financial Results — Q3 2009 revenuereased 106.3% to $15.6 million; Q3 Gross Margins of 77.0% — Q3 2009 netomereased 459.2% to $3.1 million with EPS of $0.13 — Revenue for the first nine monthsreased 52.5 % to $36.2 million; netomereased 112.9% to $8.8 million with EPS of $0.37

---

---

Webplus: BSPM/20091113/8-K/1/000.htm SEC Original: biostar8k111309.htm
FORM 8-K CURRENT REPORT November 12, 2009te of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, Maryland 333-147363 20-5101287 (State or other jurisdiction oforporation) (Commission (IRS Employer Identification No.) Province, The Peoples Republic of China No. 588 Shiji Avenue, Xianyang City, Shaanxi 712046 (Zipde) 86- 029-33686638pies to:

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-11-13CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046